{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:22Z","timestamp":1791409882481,"version":"4.3.3"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006464","name":"BITS Pilani","doi-asserted-by":"publisher","award":["NFSG\/PIL\/2024\/P3862"],"award-info":[{"award-number":["NFSG\/PIL\/2024\/P3862"]}],"id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110343","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:22:01Z","timestamp":1786033321000},"page":"110343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural cyclic depsipeptides and their analogs as potential antimicrobial candidates: mechanistic insight"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-1416","authenticated-orcid":false,"given":"Gautam","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Engle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110343_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.70365","article-title":"Naturally occurring Coumarins as promising antimicrobial agents: latest Progress","author":"Gako","year":"2026","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bioorg.2026.110343_bb0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ddr.22063","article-title":"Natural products and their analogues acting against Mycobacterium tuberculosis: a recent update","volume":"84","author":"Kumar","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110343_bb0015","doi-asserted-by":"crossref","DOI":"10.15212\/bioi-2025-0034","article-title":"Combating multi-drug resistant Mycobacterium species by efflux pump inhibitors: contemporary trends","volume":"6","author":"Kumar","year":"2025","journal-title":"BIO Integration"},{"key":"10.1016\/j.bioorg.2026.110343_bb0020","author":"World Health Organization"},{"key":"10.1016\/j.bioorg.2026.110343_bb0025","series-title":"World Malaria Report 2025 Addressing the Threat of Antimalarial Drug Resistance","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110343_bb0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41579-024-01062-w","article-title":"The pathobiology of human fungal infections","volume":"22","author":"Brown","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0035","series-title":"Antimicrobial Resistance Multi-Partner Trust Fund Forging Tripartite collaboration for urgent global and country action against antimicrobial resistance (AMR) Annual Progress Report 2020","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.bioorg.2026.110343_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301998","article-title":"Exploring the antimicrobial potential of pyrimidine linked Hydrazinyl azole derivatives: insights from biological assays and molecular docking studies","volume":"8","author":"Kumar","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110343_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204927","article-title":"Bis(azolyl)pyridine-2,6-dicarboxamide derivatives: synthesis, bioassay analysis and molecular docking studies","volume":"8","author":"Bharath kumar","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110343_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tifs.2021.01.005","article-title":"The structure-mechanism relationship and mode of actions of antimicrobial peptides: a review","volume":"109","author":"Li","year":"2021","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2017.06.002","article-title":"Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications","volume":"95","author":"Lee","year":"2017","journal-title":"Peptides (N.Y.)."},{"key":"10.1016\/j.bioorg.2026.110343_bb0060","article-title":"Antimicrobial peptides: a new frontier in antifungal","author":"De Cesare","year":"2020","journal-title":"Therapy"},{"key":"10.1016\/j.bioorg.2026.110343_bb0065","doi-asserted-by":"crossref","first-page":"14794","DOI":"10.1021\/acs.jafc.6c01397","article-title":"Chemistry and biology of antifungal cyclic peptides","volume":"74","author":"Zhang","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0070","article-title":"Structural diversity and biological activities of cyclic depsipeptides from fungi","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110343_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11121772","article-title":"Cell-penetrating antimicrobial peptides with anti-infective activity against intracellular pathogens","volume":"11","author":"Cruz","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110343_bb0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/iub.2244","article-title":"Targeting plasmodium with constrained peptides and peptidomimetics","volume":"72","author":"Helton","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bioorg.2026.110343_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.lwt.2018.09.028","article-title":"The apoptosis of Staphylococcus aureus induced by glycinin basic peptide through ROS oxidative stress response","volume":"99","author":"Ning","year":"2019","journal-title":"Lwt"},{"key":"10.1016\/j.bioorg.2026.110343_bb0090","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10989-019-09946-9","article-title":"Antimicrobial peptides (AMPs): roles, functions and mechanism of action","volume":"26","author":"Seyfi","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.bioorg.2026.110343_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4155\/fmc-2017-0315","article-title":"Cyclic lipodepsipeptides: time for a concerted action to unlock their application potential?","volume":"10","author":"Geudens","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01589-18","article-title":"Daptomycin pore formation and stoichiometry depend on membrane potential of target membrane","volume":"63","author":"Seydlov\u00e1","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110343_bb0105","first-page":"1311","article-title":"Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria, future","volume":"5","author":"Bionda","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0110","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.jmb.2019.05.014","article-title":"Docking on lipid II\u2014A widespread mechanism for potent bactericidal activities of antibiotic peptides","volume":"431","author":"Grein","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00343","article-title":"Production of ramoplanin and ramoplanin analogs by actinomycetes","volume":"8","author":"de la Cruz","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0120","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/AAC.04853-14","article-title":"Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model","volume":"59","author":"Kraus","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110343_bb0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bmc.2016.01.014","article-title":"Semisynthetic routes to PF1022H - a precursor for new derivatives of the anthelmintic cyclooctadepsipeptide PF1022A","volume":"24","author":"Sivanathan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exppara.2011.08.012","article-title":"Emodepside and SL0-1 potassium channels: a review","volume":"132","author":"Martin","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0135","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1111\/bcp.14816","article-title":"Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects","volume":"87","author":"Gillon","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00464-5","article-title":"Emodepside for strongyloidiasis: insights from parasite genetics","volume":"25","author":"Jin","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0145","doi-asserted-by":"crossref","first-page":"32080","DOI":"10.1039\/D5RA03414K","article-title":"Diverse chemotypes of polyketides as promising antimicrobial agents: latest progress","volume":"15","author":"Kumar","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110343_bb0150","series-title":"WHO Bacterial Priority Pathogens List, 2024:Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110343_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118930","article-title":"Exploring diverse chemotypes of natural polyenes as promising antimicrobial candidates: latest progress and limitations","volume":"314","author":"Kumar","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0160","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS), n.d."},{"key":"10.1016\/j.bioorg.2026.110343_bb0165","series-title":"Global Strategy on Infection Prevention and Control","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110343_bb0170","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bioorg.2026.110343_bb0175","unstructured":"P. Cardoso, H. Glossop, T.G. Meikle, A. Aburto-Medina, C.E. Conn, V. Sarojini, C. Valery, Molecular Engineering of Antimicrobial Peptides: Microbial Targets, Peptide Motifs and Translation Opportunities, (n.d.). doi:https:\/\/doi.org\/10.1007\/s12551-021-00784-y\/Published."},{"key":"10.1016\/j.bioorg.2026.110343_bb0180","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/AAC.01050-16","article-title":"Dual targeting of cell wall precursors by teixobactin leads to cell lysis","volume":"60","author":"Homma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110343_bb0185","first-page":"980","article-title":"Biochimica et Biophysica Acta molecular mechanisms of membrane targeting antibiotics \u2606","volume":"2016","author":"Epand","year":"1858","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.bioorg.2026.110343_bb0190","article-title":"Bacterial cell envelope-targeting antibiotics","author":"Ntallis","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.humic.2019.01.001","article-title":"Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents","volume":"11","author":"Belete","year":"2019","journal-title":"Hum. Microb. J."},{"key":"10.1016\/j.bioorg.2026.110343_bb0200","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1039\/D2NP00084A","article-title":"Natural products acting against S. Aureus through membrane and cell wall disruption","volume":"40","author":"Kumar","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2026.110343_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1134\/S0026893325700013","article-title":"Components of bacterial cell walls as targets for searching for new antibacterial compounds: methods of study","volume":"59","author":"Chingizova","year":"2025","journal-title":"Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C7NP00012J","article-title":"Targeting a cell wall biosynthesis hot spot","volume":"34","author":"M\u00fcller","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2026.110343_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijmm.2009.10.005","article-title":"An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway","volume":"300","author":"Schneider","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.plefa.2008.09.020","article-title":"Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics","volume":"79","author":"de Kruijff","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bioorg.2026.110343_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112262","article-title":"Breaking down the cell wall: strategies for antibiotic discovery targeting bacterial transpeptidases","volume":"194","author":"Cochrane","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0230","first-page":"3062","article-title":"Structural variations of the cell wall precursor lipid II in gram-positive bacteria - impact on binding and efficacy of antimicrobial peptides","volume":"2015","author":"M\u00fcnch","year":"1848","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bioorg.2026.110343_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118188","article-title":"Potential next generation targets for antibacterial agent\u2019s discovery and development","volume":"301","author":"Gupta","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0240","article-title":"Breaking down the cell wall: still an attractive antibacterial strategy","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0245","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1021\/acs.chemrev.0c00587","article-title":"Assembly and maintenance of lipids at the bacterial outer membrane","volume":"121","author":"Lundstedt","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110343_bb0250","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1039\/C7RA12950E","article-title":"Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism","volume":"8","author":"Boersch","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110343_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5582\/ddt.2016.01041","article-title":"Menaquinone as a potential target of antibacterial agents","volume":"10","author":"Paudel","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.bioorg.2026.110343_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.sbi.2020.05.005","article-title":"Advances in menaquinone biosynthesis: sublocalisation and allosteric regulation","volume":"65","author":"Johnston","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0265","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00171-22","article-title":"Lysocin E targeting Menaquinone in the membrane of Mycobacterium tuberculosis is a promising Lead compound for Antituberculosis drugs","volume":"66","author":"Geberetsadik","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110343_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05252-w","article-title":"The bacterial DNA sliding clamp, \u03b2-clamp: structure, interactions, dynamics and drug discovery","volume":"81","author":"Simonsen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2018.00087","article-title":"DNA sliding clamps as therapeutic targets","volume":"5","author":"Altieri","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0280","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1093\/nar\/gkx665","article-title":"Mechanism of opening a sliding clamp","volume":"45","author":"Douma","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110343_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12013-016-0764-3","article-title":"Sliding clamp of DNA polymerase III as a drug target for TB therapy: comprehensive conformational and binding analysis from molecular dynamic simulations","volume":"74","author":"Machaba","year":"2016","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2026.110343_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-023-00164-w","article-title":"Biofilm formation: mechanistic insights and therapeutic targets","volume":"4","author":"Wang","year":"2023","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.bioorg.2026.110343_bb0295","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","article-title":"The biofilm life cycle: expanding the conceptual model of biofilm formation","volume":"20","author":"Sauer","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0300","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1007\/s00253-022-12150-3","article-title":"Biofilm formation and inhibition mediated by bacterial quorum sensing","volume":"106","author":"Wang","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0305","article-title":"Mimicking biofilm formation and development: recent progress in in vitro and in vivo biofilm models","volume":"24","author":"Guzm\u00e1 N-Soto","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.bioorg.2026.110343_bb0310","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jgar.2019.11.012","article-title":"Non-antibiotic antimicrobial agents to combat biofilm-forming bacteria","volume":"21","author":"Cao","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bioorg.2026.110343_bb0315","doi-asserted-by":"crossref","first-page":"12556","DOI":"10.1074\/jbc.R116.722710","article-title":"Impact of environmental cues on staphylococcal quorum sensing and biofilm development","volume":"291","author":"Kavanaugh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-024-00323-8","article-title":"The role of Staphylococcus aureus quorum sensing in cutaneous and systemic infections","volume":"44","author":"Yamazaki","year":"2024","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.bioorg.2026.110343_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-023-08930-3","article-title":"Deciphering agr quorum sensing in Staphylococcus aureus: insights and therapeutic prospects","volume":"51","author":"Vinodhini","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2026.110343_bb0330","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/1040841X.2019.1700209","article-title":"Pseudomonas aeruginosa and Staphylococcus aureus communication in biofilm infections: insights through network and database construction","volume":"45","author":"Magalh\u00e3es","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-micro-102215-095708","article-title":"Staphylococcus aureus RNAIII and its regulon link quorum sensing, stress responses, metabolic adaptation, and regulation of virulence gene expression","volume":"70","author":"Bronesky","year":"2016","journal-title":"Ann. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.80","article-title":"Surface-attached molecules control Staphylococcus aureus quorum sensing and biofilm development","volume":"2","author":"Kim","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0345","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110343_bb0350","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1002\/chem.201704167","article-title":"Chemistry and biology of Teixobactin","volume":"24","author":"Guo","year":"2018","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2026.110343_bb0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.drudis.2016.11.015","article-title":"Recent developments in natural product-based drug discovery for tuberculosis","volume":"22","author":"Dong","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110343_bb0360","first-page":"1937","article-title":"Total synthesis of the Tiacumicin B ( Lipiarmycin A3 \/ Fidaxomicin )","author":"Glaus","year":"2015","journal-title":"Aglycone ** Angewandte"},{"key":"10.1016\/j.bioorg.2026.110343_bb0365","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/acssynbio.0c00248","article-title":"Enhanced production of active ecumicin component with higher antituberculosis activity by the rare actinomycete nonomuraea sp. MJM5123 using a novel promoter-engineering strategy","volume":"9","author":"Su","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0370","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/nyas.14282","article-title":"Synthesis and structure \u2212 activity relationships of teixobactin","volume":"1459","author":"Karas","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16600-2","article-title":"Mode of action of teixobactins in cellular membranes","volume":"11","author":"Shukla","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110343_bb0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41586-022-05019-y","article-title":"Teixobactin kills bacteria by a two-pronged attack on the cell envelope","volume":"608","author":"Shukla","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110343_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00077-20","article-title":"The killing mechanism of Teixobactin against methicillin-resistant Staphylococcus aureus: an untargeted metabolomics study","volume":"5","author":"Hussein","year":"2020","journal-title":"MSystems"},{"key":"10.1016\/j.bioorg.2026.110343_bb0390","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/acsinfecdis.4c00835","article-title":"Teixobactin: a resistance-evading antibiotic for treating Anthrax","volume":"11","author":"Lawrence","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0395","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-024-03857-9","article-title":"Novel Teixobactin analogues show promising in vitro activity on biofilm formation by Staphylococcus aureus and enterococcus faecalis","volume":"81","author":"Amer","year":"2024","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115853","article-title":"Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms","volume":"261","author":"Parmar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0405","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.cell.2023.07.038","article-title":"An antibiotic from an uncultured bacterium binds to an immutable target","volume":"186","author":"Shukla","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110343_bb0410","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1021\/acs.joc.4c01414","article-title":"Structure-activity relationship studies of the peptide antibiotic Clovibactin","volume":"89","author":"Brunicardi","year":"2024","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0415","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/acsinfecdis.5c00458","article-title":"Efficient synthesis of Clovibactin and its analogues: promoting the discovery of more potent antibiotics via multiple screenings","volume":"11","author":"He","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0420","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.joc.4c02828","article-title":"Potent analogues of Clovibactin from commercially available amino acid building blocks","volume":"90","author":"Brunicardi","year":"2025","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202410286","article-title":"Calcium-dependent Lipopeptide antibiotics against drug-resistant pathogens discovered via host-dependent heterologous expression of a cloned biosynthetic gene cluster","volume":"63","author":"Lai","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110343_bb0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1039\/D3SC01944F","article-title":"Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis","volume":"15","author":"Marschall","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0435","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cbic.202000555","article-title":"Discovery of Six Ramoplanin Family Gene Clusters and the Lipoglycodepsipeptide Chersinamycin","volume":"22","author":"Morgan","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2026.110343_bb0440","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/jacs.5b11807","article-title":"The mechanism of action of Lysobactin","volume":"138","author":"Lee","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110343_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65287-w","article-title":"The last resort antibiotic daptomycin exhibits two independent antibacterial mechanisms of action","volume":"16","author":"Buttress","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110343_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15257-1","article-title":"Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids","volume":"11","author":"Grein","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110343_bb0455","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1021\/acs.orglett.3c04195","article-title":"Dilarmycins A-C, calcium-dependent Lipopeptide antibiotics with a non-canonical Ca2+-binding motif","volume":"26","author":"Fern\u00e1ndez-Pastor","year":"2024","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.110343_bb0460","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/acs.joc.9b02922","article-title":"Total synthesis of analogs of A54145D and A54145A1 for structure-activity relationship studies","volume":"85","author":"Kralt","year":"2020","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202114858","article-title":"The chiral target of Daptomycin is the 2R,2\u2032S stereoisomer of Phosphatidylglycerol","volume":"61","author":"Moreira","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110343_bb0470","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/acs.jmedchem.9b01957","article-title":"Methylation of Daptomycin leading to the discovery of Kynomycin, a cyclic Lipodepsipeptide active against resistant pathogens","volume":"63","author":"Chow","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0475","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bmc.2018.12.004","article-title":"The effect of replacing the ester bond with an amide bond and of overall stereochemistry on the activity of daptomycin","volume":"27","author":"Moreira","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0480","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acsinfecdis.4c00810","article-title":"The calcium-dependent antibiotics: structure-activity relationships and determination of their lipid target","volume":"11","author":"Goodyear","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0485","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1021\/acs.orglett.9b02333","article-title":"Identification of an anti-MRSA cyclic Lipodepsipeptide, WBP-29479A1, by genome Mining of Lysobacter antibioticus","volume":"21","author":"Sang","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.110343_bb0490","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/1573407215666190318125023","article-title":"Modification in the natural bioactive molecule: Piperine; a continuing source for the drug development","volume":"16","author":"Chopra","year":"2020","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.bioorg.2026.110343_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26702-0","article-title":"Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus","volume":"12","author":"Hamamoto","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110343_bb0500","doi-asserted-by":"crossref","first-page":"16912","DOI":"10.1002\/chem.201604022","article-title":"Total synthesis and functional evaluation of fourteen derivatives of Lysocin E: importance of cationic, hydrophobic, and aromatic moieties for antibacterial activity","volume":"22","author":"Kaji","year":"2016","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2026.110343_bb0505","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41564-021-01013-8","article-title":"Identification of structurally diverse menaquinone-binding antibiotics with in vivo activity against multidrug-resistant pathogens","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0510","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-07159-5","article-title":"Discovery of a family of menaquinone-targeting cyclic lipodepsipeptides for multidrug-resistant gram-positive pathogens","volume":"7","author":"Sun","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0515","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1021\/acs.joc.7b02318","article-title":"Total synthesis and biological mode of action of WAP-8294A2: a Menaquinone-targeting antibiotic","volume":"83","author":"Itoh","year":"2018","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0520","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/acssynbio.7b00293","article-title":"Yield improvement of the anti-MRSA antibiotics WAP-8294A by CRISPR\/dCas9 combined with refactoring self-protection genes in Lysobacter enzymogenes OH11","volume":"7","author":"Yu","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0525","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acsinfecdis.4c00018","article-title":"Identification of an optimized clinical development candidate from Cilagicin, an antibiotic that evades resistance by dual Polyprenyl phosphate binding","volume":"10","author":"Rosenzweig","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0530","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1021\/acscentsci.4c00776","article-title":"Exploring structure\u2212activity relationships and modes of action of Laterocidine","volume":"10","author":"Thombare","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0535","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acs.jnatprod.1c00222","article-title":"The Total chemical synthesis and biological evaluation of the cationic antimicrobial peptides, Laterocidine and Brevicidine","volume":"84","author":"Hermant","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0540","article-title":"New strain Brevibacillus laterosporus TSA31-5 produces both brevicidine and brevibacillin, exhibiting distinct antibacterial modes of action against gram-negative and gram-positive bacteria","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110343_bb0545","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1021\/acs.jnatprod.3c00876","article-title":"Synthesis, structure-activity relationship study, bioactivity, and nephrotoxicity evaluation of the proposed structure of the cyclic Lipodepsipeptide Brevicidine B","volume":"87","author":"Palpal-Latoc","year":"2024","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0550","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1039\/D2SC00143H","article-title":"Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy","volume":"13","author":"Al Ayed","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110343_bb0555","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/acsinfecdis.3c00043","article-title":"Total synthesis and structure assignment of the Relacidine Lipopeptide antibiotics and preparation of analogues with enhanced stability","volume":"9","author":"Al Ayed","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0560","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1021\/acs.jnatprod.1c00547","article-title":"Skyllamycins D and E, non-ribosomal cyclic Depsipeptides from lichen-sourced Streptomyces anulatus","volume":"84","author":"Bracegirdle","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0565","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1021\/acs.jnatprod.5b00540","article-title":"Arthroamide, a cyclic Depsipeptide with quorum sensing inhibitory activity from Arthrobacter sp","volume":"78","author":"Igarashi","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"2015","key":"10.1016\/j.bioorg.2026.110343_bb0570","first-page":"1106","article-title":"Targeting DnaN for tuberculosis therapy using novel griselimycins","volume":"348","author":"Kling","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110343_bb0575","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2015.08.002","article-title":"New Griselimycins for treatment of tuberculosis","volume":"22","author":"Holzgrabe","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-07175-5","article-title":"Exquisite selectivity of griselimycin extends to beta subunit of DNA polymerases from gram-negative bacterial pathogens","volume":"7","author":"Fenwick","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0585","article-title":"Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins","volume":"15","author":"Fu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110343_bb0590","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/acs.orglett.9b00618","article-title":"Discovery and biosynthesis of Atrovimycin, an Antitubercular and antifungal Cyclodepsipeptide featuring vicinal-dihydroxylated Cinnamic acyl chain","volume":"21","author":"Liu","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.110343_bb0595","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1021\/acs.orglett.9b00208","article-title":"Genome mining of Streptomyces atratus SCSIO ZH16: discovery of Atratumycin and identification of its biosynthetic gene cluster","volume":"21","author":"Sun","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.110343_bb0600","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1021\/acs.jnatprod.0c00194","article-title":"Production of Antitubercular Depsipeptides via biosynthetic engineering of Cinnamoyl units","volume":"83","author":"Yang","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131497","article-title":"A cyclic lipodepsipeptide, a spirolactone, and a chromanone from the marine fungus Verruculina enalia (Kohlm.) Kohlm. & Volkm.-Kohlm. BCC 22226","volume":"76","author":"Bunyapaiboonsri","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110343_bb0610","doi-asserted-by":"crossref","first-page":"23005","DOI":"10.1002\/anie.202009611","article-title":"Discovery of a cryptic Depsipeptide from Streptomyces ghanaensis via MALDI-MS-guided high-throughput elicitor screening","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.110343_bb0615","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/acs.joc.9b00364","article-title":"Total synthesis of Paenibacterin and its analogues","volume":"84","author":"Noden","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110343_bb0620","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1021\/acsinfecdis.2c00157","article-title":"Effect of lipid length and cationic residues on the antibacterial and hemolytic activities of Paenibacterin","volume":"8","author":"Noden","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107713","article-title":"Interaction of beauvericin in combination with antibiotics against methicillin-resistant Staphylococcus aureus and Salmonella typhimurium","volume":"243","author":"V\u00e1squez Bonilla","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2026.110343_bb0630","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1021\/acs.jnatprod.0c00294","article-title":"Krisynomycins, imipenem potentiators against methicillin-resistant staphylococcus aureus, produced by streptomyces canus","volume":"83","author":"Perez-Bonilla","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.enzmictec.2024.110477","article-title":"Control of Staphylococcus epidermidis biofilm by surfactins of an endophytic bacterium Bacillus sp. 15 F","volume":"180","author":"Jardak","year":"2024","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0640","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acschembio.0c00568","article-title":"Isopedopeptins A-H: cationic cyclic lipodepsipeptides from Pedobacter cryoconitis UP508 targeting WHO top-priority carbapenem-resistant bacteria","volume":"15","author":"Nord","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0645","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acs.jnatprod.3c00993","article-title":"Serratiomycins D1-D3, antibacterial cyclic peptides from a Serratia sp. and structure revision of Serratiomycin","volume":"87","author":"Du","year":"2024","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0650","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1021\/acsomega.4c10990","article-title":"New antimicrobial Cyclodepsipeptides from a freshwater fungus from the Sierra Madre oriental in Mexico","volume":"10","author":"Yeverino","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110343_bb0655","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00253-017-8669-7","article-title":"The antibacterial activity of LI-F type peptide against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and inhibition of infections in murine scalded epidermis","volume":"102","author":"Han","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0660","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jam.13526","article-title":"The antibacterial activity and modes of LI-F type antimicrobial peptides against Bacillus cereus in vitro","volume":"123","author":"Han","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0665","series-title":"Antifungal Agents in Clinical and Preclinical Development Overview and Analysis","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110343_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116400","article-title":"Tackling multi-drug resistant fungi by efflux pump inhibitors","volume":"226","author":"Engle","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110343_bb0675","unstructured":"World Health Organization, WHO fungal priority pathogens list to guide research, development and public health action, (n.d.). https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/69af4379-4f27-4ac4-8973-74d7b52af7bd\/content (accessed May 1, 2026)."},{"key":"10.1016\/j.bioorg.2026.110343_bb0680","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bioorg.2026.110343_bb0685","article-title":"Current methods for the detection of plasmodium parasite species infecting humans","volume":"2","author":"Slater","year":"2022","journal-title":"Curr. Res. Parasitol. Vector-Borne Dis."},{"key":"10.1016\/j.bioorg.2026.110343_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128013","article-title":"Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin a against Cryptococcus neoformans","volume":"41","author":"Teymuri","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110343_bb0695","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/jacs.2c11107","article-title":"Ecological niche-inspired genome mining leads to the discovery of crop-protecting nonribosomal Lipopeptides featuring a transient amino acid building block","volume":"145","author":"G\u00f6tze","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110343_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9060278","article-title":"Structural elucidation of antibiotic tkr2999, an antifungal lipodepsipeptide isolated from the fungus foliophoma fallens","volume":"9","author":"Crespo","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110343_bb0705","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tet.2016.12.033","article-title":"Enduspeptides A-F, six new cyclic depsipeptides from a coal mine derived Streptomyces sp","volume":"73","author":"Chen","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110343_bb0710","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mycmed.2017.11.007","article-title":"Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus","volume":"28","author":"Makarasen","year":"2018","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"10.1016\/j.bioorg.2026.110343_bb0715","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10286020.2017.1320989","article-title":"Fusaripeptide a: new antifungal and anti-malarial cyclodepsipeptide from the endophytic fungus fusarium sp","volume":"20","author":"Ibrahim","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2026.110343_bb0720","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cbic.201900665","article-title":"Phototemtide a, a cyclic Lipopeptide Heterologously expressed from Photorhabdus temperata Meg1, shows selective antiprotozoal activity","volume":"21","author":"Zhao","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2026.110343_bb0725","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/acs.jnatprod.4c00499","article-title":"Wajeepeptin, a cytotoxic and Antitrypanosomal cyclic Depsipeptide from a marine Moorena sp. cyanobacterium","volume":"87","author":"Kurisawa","year":"2024","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0730","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/acs.jnatprod.7b00034","article-title":"Dudawalamides A-D, Antiparasitic cyclic Depsipeptides from the marine cyanobacterium Moorea producens","volume":"80","author":"Almaliti","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110343_bb0735","article-title":"Genome-guided discovery of antimalarial 4-amino-2,4-pentadienoate-containing cyclolipodepsipeptides","author":"Candra","year":"2026","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:26Z","timestamp":1791407366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":147,"alternative-id":["S0045206826008795"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110343","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural cyclic depsipeptides and their analogs as potential antimicrobial candidates: mechanistic insight","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110343"}}